¡@¡@¬¡°Ê©Êµ²®Ö¯fªºµo¯fì¦]¡A«Ü«nªº¤@Ó¬O쥻îh¥ñ¦bÅ餺ªºµ²®Öµß©ó±J¥D©è§Ü¤O°§C®É¦A¬¡¤Æ¦Ó¾ÉP¡C¦]¦¹¡A¦pªG¯à°÷¦´Á¶EÂ_¼ç¥ñ©Êµ²®Ö¯f¡]latent tuberculosis infection¡^¡A¨Ã¥B¥[¥HªvÀø¡A«K¥i¥H´î¤Ö¤é«á²£¥Í¬¡°Ê©Êµ²®Ö¯fªº¾÷·|¡C¥Ø«e¶EÂ_¼ç¥ñ©Êµ²®Ö¯fªº¤èªk¡A¨Æ¹ê¤W³£¤£¬O¦Ê¤À¤§¦Ê·Ç½T¡A¦ý±`¥Îªº¤èªk¦³¨âºØ¡A¥]¬A¡yµ²®Öµß¯À¥Ö¤U´ú¸Õ¡z¡y¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªR¡z¡C¥Ñ©ó«eªÌ¨Ï¥Î¤F³\¦hµ²®Öµßªº«D¯S²§©Ê§Üì¡A³y¦¨·Ç½T«×°§C¡A¯S§O¬O¦b¤j¶q±µºØ¥d¤¶]ªº¦a°Ï¡C¥[¤W»Ýn¨â¦¸ªº¦^¶E¡AÁ{§É¹ê¥Î¤W¤Q¤À¤£¤è«K¡C
¡@¡@¹L¥h´X¦~¤º¡AÅé¥~T²ÓM§K¬ÌÀË´ú¤è¦¡³Qµo®i¥X¨Ó¡A¨Ã¥B¶i¤@¨B³]p¦¨°Ó·~¤Æ¸Õ¾¯¡]T-SPOT TB¡BQuantiFERON TB-Gold¡^¡A³o¨Ç¸Õ¾¯¦bì²z¤W¬O¤j¦P¤p²§¡A³qºÙ¬°¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªR¡]Interferon-£^ Release Assays¡^¡C»Pµ²®Öµß¯À¥Ö½§´ú¸Õ³Ì¤jªº®t§O¦b©ó©Ò¿ï¾Üªº§Üì¬Oµ²®Öµßªº¯S²§©Ê§Üì¡A¥]¬AESAT-6¡]early secreted antigenic substance ¡V 6 kD¡^¡BCFP-10¡]culture filtrated protein ¡V 10 kD¡^¡B¥H¤ÎTB7.7¡A¤j¦h¼Æªº«D¨å«¬¤ÀªK±ìµß¥H¤ÎM. bovis BCG³£¤£¨ã¦³³o´XÓ§Üì¡C¨ü¸ÕªÌªº¶gÃä¦å²G»P³o¨Ç¯S²§©Ê§Üì¸g¹L¹j©]Åé¥~°ö¾i¨ë¿E«á¡A°»´ú§K¬Ì²ÓM©ÒÄÀ©ñ¤§¤þ«¬¤zÂZ¯À¡AÂÇ¥Hµû¦ô¶gÃä¦å²G¤º¹ï³o¨Çµ²®Öµß¯S²§©Ê§Üì¨ã¦³±M¤@©Ê¤§effector T²ÓMªº¶q¡C¥Ø«e¬ü°êªºCenters for Disease Control and Prevention¤w¸g«Øij¨Ï¥ÎQuantiFERON TB-Gold¨ú¥Nµ²®Öµß¯À¥Ö½§´ú¸Õ¡A¦Ó^°êªºNational Institute for Clinical Excellence¤]«Øij¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªR¥i¥H§@¬°µ²®Öµß¯À¥Ö½§´ú¸Õªº»²§U¤u¨ã¡C
¡@¡@®Ú¾Ú¥Ø«eªº¬ã¨s¡A¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªR¹ï©ó¤½¦@½Ã¥Í¤Wªºµ²®Ö¯f¼ÉÅS½Õ¬d¡A·Ç½T«×§¡¸ûµ²®Öµß¯À¥Ö½§´ú¸Õ°ª¡CµM¦Ó¡A¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªR³Ì¤jªº¯Ê³´¬OµLªk°Ï¤À¥X¬¡°Ê©Êµ²®Ö¯f©M¼ç¥ñ©Êµ²®Ö¯f¡C¶§©Êªº¤þ«¬¤zÂZ¯ÀÄÀ©ñ¤ÀªRµ²ªG¡A¥i¯à¥u¥Nªí±wªÌ³Ìªñ´¿³Qµ²®Öµß·P¬V¡AµLªk½T»{¯f¨_¯u¥¿¬O¬¡°Ê©Êµ²®Ö¯f¡C